VC-backed Monte Rosa Therapeutics debuts IPO
Monte Rosa Therapeutics Inc, a developer of small molecule precision medicines, has raised about $222.3 million for its IPO after pricing its 11.7 million shares at $19 per share.
24 June 2021•3 mins read
Monte Rosa Therapeutics Inc, a developer of small molecule precision medicines, has raised about $222.3 million for its IPO after pricing its 11.7 million shares at $19 per share.
